Gandek Barbara, Ware John E
University of Massachusetts Medical School, Worcester, and John Ware Research Group, Watertown, Massachusetts.
Arthritis Care Res (Hoboken). 2017 Jun;69(6):817-825. doi: 10.1002/acr.23193. Epub 2017 May 8.
To evaluate validity and responsiveness of the Knee Injury and Osteoarthritis Outcome Score (KOOS) in relation to other patient-reported outcome measures before and after total knee replacement (TKR).
Pre-TKR and 6-month post-TKR data from 1,143 patients in a US joint replacement cohort were used to compare the KOOS, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the SF-36 Health Survey (SF-36). Validity was evaluated with multiple methods, including correlations of pre-TKR scale scores and analysis of variance models that used pre-TKR data to compare the relative validity of scales in discriminating between groups differing in assistive walking device use and number of comorbid conditions. Validity was also evaluated by using post-TKR minus pre-TKR change scores to assess relative validity of scales in discriminating between groups rating themselves as better, same, or worse (BSW) in their capability to do activities at 6 months. Responsiveness also was described using effect sizes and standardized response means.
In support of convergent and discriminant validity, KOOS scale scores were worse for patients using an assistive device but only declined weakly with increasing comorbid conditions. While all knee-specific scales discriminated between BSW groups, the KOOS quality of life (QOL) scale was significantly better (P < 0.05) than all measures except the SF-36 physical component summary. KOOS QOL also had the highest effect size, while SF-36 measures had lower effect sizes and standardized response means. KOOS pain and symptoms scales discriminated better than WOMAC pain and stiffness scales among BSW groups.
KOOS scales were valid and responsive in this cohort of US TKR patients. KOOS QOL performed particularly well in capturing aggregate knee-specific outcomes.
评估全膝关节置换术(TKR)前后膝关节损伤与骨关节炎疗效评分(KOOS)相对于其他患者报告结局指标的有效性和反应性。
使用美国关节置换队列中1143例患者的TKR术前和术后6个月的数据,比较KOOS、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)以及SF-36健康调查(SF-36)。采用多种方法评估有效性,包括TKR术前量表评分的相关性以及方差分析模型,该模型使用TKR术前数据比较量表在区分使用辅助行走设备情况和合并症数量不同的组之间的相对有效性。还通过使用TKR术后减去术前的变化分数来评估量表在区分6个月时自我评估为活动能力变好、相同或变差(BSW)的组之间的相对有效性。反应性也使用效应量和标准化反应均值进行描述。
为支持聚合效度和区分效度,使用辅助设备的患者KOOS量表评分更差,但仅随合并症数量增加而微弱下降。虽然所有膝关节特异性量表都能区分BSW组,但KOOS生活质量(QOL)量表显著优于除SF-36身体成分总结外的所有指标(P < 0.05)。KOOS QOL的效应量也最高,而SF-36指标的效应量和标准化反应均值较低。在BSW组中,KOOS疼痛和症状量表比WOMAC疼痛和僵硬量表的区分度更好。
KOOS量表在该美国TKR患者队列中具有有效性和反应性。KOOS QOL在捕捉总体膝关节特异性结局方面表现尤其出色。